Usnoflast well tolerated, shows signs of efficacy in ALS patients - ALS News Today
Last Updated: 25.06.2025 11:01
That… [+4080 chars]
An experimental oral treatment from Zydus Lifesciences was well tolerated at all tested doses and showed signs of slowing disease progression in people with amyotrophic lateral sclerosis (ALS).